Cargando…
111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases
The great milestones in medicine almost always have their precursors, which help the great event to break through. So it was with allergen-specific immunotherapy (AIT) and the great work of Noon and Freeman and their world-renowned publication in 1911. In this article, we want to outline AIT’s long...
Autores principales: | Gutermuth, Jan, Grosber, Martine, Pfaar, Oliver, Bergmann, Karl Christian, Ring, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707371/ https://www.ncbi.nlm.nih.gov/pubmed/36457720 http://dx.doi.org/10.5414/ALX02330E |
Ejemplares similares
-
Acrokeratosis Can Be a Warning Sign of an Underlying Malignancy
por: Nguyen, Sara, et al.
Publicado: (2019) -
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
por: Pfaar, Oliver, et al.
Publicado: (2015) -
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020) -
Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases
por: Zahirović, Abida, et al.
Publicado: (2018) -
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)